InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Krainer Adrian R.. Director active across 1 company, notably Stoke Therapeutics, Inc.. Aggregated, 1 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €453k. Activity tracked since 14 November 2025. The latest transaction was disclosed on 14 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration